Similar articles for PMID: 31102000

Year	Number of Results
2001	1
2003	2
2004	5
2005	4
2006	3
2007	5
2008	6
2009	8
2010	3
2011	10
2012	7
2013	13
2014	12
2015	15
2016	13
2017	18
2018	12
2019	17
2020	29
2021	26
2022	23
2023	5
2024	0

1

Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial.

Zanoni L, Broccoli A, Lambertini A, Pellegrini C, Stefoni V, Lodi F, Fonti C, Nanni C, Zinzani PL, Fanti S. Zanoni L, et al. Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1661-1671. doi: 10.1007/s00259-019-04323-6. Epub 2019 May 17. Eur J Nucl Med Mol Imaging. 2019. PMID: 31102000 Clinical Trial.

2

A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.

Mena E, Lindenberg ML, Turkbey BI, Shih J, Logan J, Adler S, Wong K, Wilson W, Choyke PL, Kurdziel KA. Mena E, et al. Clin Nucl Med. 2014 Oct;39(10):874-81. doi: 10.1097/RLU.0000000000000539. Clin Nucl Med. 2014. PMID: 25144214 Free PMC article.

3

(18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.

Rayamajhi SJ, Mittal BR, Maturu VN, Agarwal R, Bal A, Dey P, Shukla J, Gupta D. Rayamajhi SJ, et al. Ann Nucl Med. 2016 Apr;30(3):207-16. doi: 10.1007/s12149-015-1047-6. Epub 2015 Dec 11. Ann Nucl Med. 2016. PMID: 26661845 Clinical Trial.

4

Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.

Vera P, Bohn P, Edet-Sanson A, Salles A, Hapdey S, Gardin I, Ménard JF, Modzelewski R, Thiberville L, Dubray B. Vera P, et al. Radiother Oncol. 2011 Jan;98(1):109-16. doi: 10.1016/j.radonc.2010.10.011. Epub 2010 Nov 4. Radiother Oncol. 2011. PMID: 21056487

5

18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.

Wondergem MJ, Rizvi SN, Jauw Y, Hoekstra OS, Hoetjes N, van de Ven PM, Boellaard R, Chamuleau ME, Cillessen SA, Regelink JC, Zweegman S, Zijlstra JM. Wondergem MJ, et al. J Nucl Med. 2015 Feb;56(2):216-21. doi: 10.2967/jnumed.114.149625. Epub 2015 Jan 15. J Nucl Med. 2015. PMID: 25593118 Free article. Clinical Trial.

6

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

7

Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?

Schaefferkoetter JD, Carlson ER, Heidel RE. Schaefferkoetter JD, et al. J Oral Maxillofac Surg. 2015 Jul;73(7):1420-8. doi: 10.1016/j.joms.2015.01.002. Epub 2015 Jan 13. J Oral Maxillofac Surg. 2015. PMID: 25869746

8

Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.

Nakajo M, Nakajo M, Jinguji M, Tani A, Kajiya Y, Tanabe H, Fukukura Y, Nakabeppu Y, Koriyama C. Nakajo M, et al. Radiology. 2013 Jun;267(3):891-901. doi: 10.1148/radiol.13121546. Epub 2013 Mar 6. Radiology. 2013. PMID: 23468571

9

18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.

Yamane T, Takaoka A, Kita M, Imai Y, Senda M. Yamane T, et al. Ann Nucl Med. 2012 Jul;26(6):478-84. doi: 10.1007/s12149-012-0597-0. Epub 2012 Apr 3. Ann Nucl Med. 2012. PMID: 22477262 Clinical Trial.

10

Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.

Herrmann K, Erkan M, Dobritz M, Schuster T, Siveke JT, Beer AJ, Wester HJ, Schmid RM, Friess H, Schwaiger M, Kleeff J, Buck AK. Herrmann K, et al. Eur J Nucl Med Mol Imaging. 2012 May;39(5):846-51. doi: 10.1007/s00259-012-2061-8. Epub 2012 Jan 26. Eur J Nucl Med Mol Imaging. 2012. PMID: 22278320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

203 results

Results by year